Yardley Wealth Management LLC trimmed its holdings in shares of The Allstate Corporation (NYSE:ALL - Free Report) by 50.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,912 shares of the insurance provider's stock after selling 1,912 shares during the quarter. Allstate comprises about 0.2% of Yardley Wealth Management LLC's investment portfolio, making the stock its 28th largest holding. Yardley Wealth Management LLC's holdings in Allstate were worth $396,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of ALL. Canandaigua National Bank & Trust Co. lifted its position in shares of Allstate by 7.0% during the 1st quarter. Canandaigua National Bank & Trust Co. now owns 9,871 shares of the insurance provider's stock valued at $2,044,000 after acquiring an additional 644 shares during the period. Ameritas Advisory Services LLC grew its stake in Allstate by 108.3% during the first quarter. Ameritas Advisory Services LLC now owns 10,197 shares of the insurance provider's stock worth $2,084,000 after buying an additional 5,301 shares in the last quarter. Monument Capital Management raised its position in shares of Allstate by 4.8% in the 1st quarter. Monument Capital Management now owns 14,969 shares of the insurance provider's stock valued at $3,100,000 after buying an additional 685 shares in the last quarter. Amalgamated Bank lifted its holdings in shares of Allstate by 1.5% during the 1st quarter. Amalgamated Bank now owns 51,909 shares of the insurance provider's stock worth $10,749,000 after acquiring an additional 788 shares during the period. Finally, Avidian Wealth Enterprises LLC boosted its position in shares of Allstate by 1.7% during the 1st quarter. Avidian Wealth Enterprises LLC now owns 3,552 shares of the insurance provider's stock worth $735,000 after acquiring an additional 59 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on ALL shares. Morgan Stanley boosted their price target on Allstate from $225.00 to $235.00 and gave the stock an "overweight" rating in a report on Tuesday, May 6th. BMO Capital Markets reaffirmed an "outperform" rating on shares of Allstate in a report on Friday, May 16th. JPMorgan Chase & Co. increased their price objective on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Keefe, Bruyette & Woods boosted their target price on shares of Allstate from $228.00 to $235.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 7th. Finally, Raymond James Financial reiterated a "strong-buy" rating and set a $250.00 price target (up from $240.00) on shares of Allstate in a report on Monday, May 5th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $225.20.
Read Our Latest Stock Report on Allstate
Allstate Stock Performance
Shares of ALL stock opened at $195.67 on Monday. The stock has a market capitalization of $51.82 billion, a PE ratio of 13.37, a PEG ratio of 1.02 and a beta of 0.35. The business's 50 day simple moving average is $200.85 and its 200 day simple moving average is $196.52. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.40 and a quick ratio of 0.40. The Allstate Corporation has a one year low of $157.50 and a one year high of $213.18.
Allstate (NYSE:ALL - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing analysts' consensus estimates of $3.98 by ($0.45). The firm had revenue of $14.30 billion for the quarter, compared to the consensus estimate of $16.41 billion. Allstate had a return on equity of 24.62% and a net margin of 6.19%. Allstate's quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the business earned $5.13 EPS. As a group, research analysts forecast that The Allstate Corporation will post 18.74 earnings per share for the current year.
Allstate Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 9th will be given a dividend of $1.00 per share. The ex-dividend date of this dividend is Monday, June 9th. This represents a $4.00 annualized dividend and a dividend yield of 2.04%. Allstate's payout ratio is 27.32%.
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.